Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments - Wikidata - wikimedia - TriplyDB

Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments

Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments

http://www.wikidata.org/entity/Q34459696

about

Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.A fully human scFv phage display library for rapid antibody fragment reformatting In vivo imaging with antibodies and engineered fragments.Nanoparticles and radiotracers: advances toward radionanomedicine Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts

P2860

Q33649756-110D0AE0-96E7-4208-93E8-1829931856E3 Q33841490-6C0FCB34-824E-4813-AF90-664A64696985 Q35635839-597AA1F7-B90F-40E1-A389-4C2B4D1BA75D Q38454458-C3E6901B-2992-4DA9-9C6D-A61D002F0949 Q38785806-78084AE5-467A-4084-A89E-772C18FFF20F Q42371513-F5ED2876-74B1-4695-9939-F4338AF6BBC7 Q57116004-6551EC2A-B976-4DE2-89DD-10D033539C2D

P2860

Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments

http://www.wikidata.org/entity/Q34459696

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@ast

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@en

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@nl

type

label

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@ast

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@en

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@nl

prefLabel

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@ast

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@en

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@nl

P1433

Q34459696-4FAC86F1-22B1-41C2-A865-D15C3B254E29

P1476

Q34459696-37D6B89C-39D2-4B73-8885-001FEE94BE19

P2093

Q34459696-16238995-E3BA-4C90-8BC1-97D567A3547D

Q34459696-2CB0BD4B-C0C1-4538-9001-44CE41D455E9

Q34459696-5B3F2DFB-C23B-4893-9A7E-110960BE3CEB

Q34459696-A93C1A06-A7CA-4790-8EB4-8DBCD8FA5ED0

Q34459696-B25D36B5-E164-43A9-8442-B1330A45476C

Q34459696-C870D4D1-6DC6-4A32-BF48-19FAF843F7A7

Q34459696-C9D349F7-B6B8-4F82-AD4E-C017762FACD0

Q34459696-F321E156-A374-4496-867A-AA35D152024A

P2860

Q34459696-0AEE5C00-9BE2-4868-A4C7-8FADE6906FA0

Q34459696-13A1F4A5-C5C1-4965-B6E8-D52D8C19AD36

Q34459696-13CF8185-0C94-43B6-9CF1-A8BD8B28D19B

Q34459696-1BA153CD-2069-4894-A1F7-857514981DE0

Q34459696-1D1D969C-33FD-4DD7-9351-BF4B06BD1D5A

Q34459696-1E5817E1-3120-447B-BE00-8AE8221E09B3

Q34459696-20C1AC76-0B4E-43C5-B8C9-D3B4BC1EDFB9

Q34459696-31000AC4-C51C-41A1-9418-6FA862194725

Q34459696-332DBD92-90F1-4DE3-9C1A-902B10948156

Q34459696-3ACE7F93-D604-4C0D-AF3C-34D0EE5F4F0F

P304

Q34459696-D596EEAB-6933-48F4-B77D-D4F2F997C555

P31

Q34459696-DB9A0FE0-E0EB-4E64-957C-555365BEB17A

P356

Q34459696-8F0C0E68-782F-4585-80A6-08A7C3E8A8B1

P433

Q34459696-B8F1B2D2-5F44-423B-83F9-3AD998E3B314

P478

Q34459696-507900EC-BFAB-48DC-8EA6-DAFE82D5C88E

P577

Q34459696-451B6C01-9C3B-4CC0-8F0A-9CBF8F1DBBC0

P698

Q34459696-7DE74895-01A6-4CF3-8A34-B6CF9F2E5D24

P932

Q34459696-9CEBD999-FAAA-4EFC-9001-B55217B202FC

P356

1535-7163.MCT-14-0363

P1433

Molecular Cancer Therapeutics

P1476

Anti-MET immunoPET for non-sma ...... fully human antibody fragments

@en

P2093

Anna M Wu

http://www.w3.org/2001/XMLSchema#string

James D Marks

http://www.w3.org/2001/XMLSchema#string

Keyu Li

http://www.w3.org/2001/XMLSchema#string

Kirstin A Zettlitz

http://www.w3.org/2001/XMLSchema#string

Parag Mallick

http://www.w3.org/2001/XMLSchema#string

Richard Tavaré

http://www.w3.org/2001/XMLSchema#string

Shannon M Mumenthaler

http://www.w3.org/2001/XMLSchema#string

Yu Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Met, metastasis, motility and more

Invasive growth: a MET-driven genetic programme for cancer and stem cells

A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens

Selecting and screening recombinant antibody libraries.

Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice

Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.

P304

2607-2617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-14-0363

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25143449

http://www.w3.org/2001/XMLSchema#string

P932

4221648

http://www.w3.org/2001/XMLSchema#string